These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21174178)

  • 1. 18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors.
    Kaira K; Murakami H; Miura S; Kaira R; Akamatsu H; Kimura M; Ono A; Tsuya A; Nakamura Y; Naito T; Takahashi T; Endo M; Yamamoto N
    Ann Nucl Med; 2011 May; 25(4):247-53. PubMed ID: 21174178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
    Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M
    Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
    De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S
    Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms.
    Terzi A; Bertolaccini L; Rizzardi G; Luzzi L; Bianchi A; Campione A; Comino A; Biggi A
    Lung Cancer; 2011 Nov; 74(2):239-43. PubMed ID: 21439670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors.
    Liu Y
    Nucl Med Commun; 2011 Jul; 32(7):554-62. PubMed ID: 21403583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression.
    Viti A; Bertolaccini L; Cavallo A; Fortunato M; Bianchi A; Terzi A
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):369-74; discussion 374. PubMed ID: 24585679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.
    Thomas A; Mena E; Kurdziel K; Venzon D; Khozin S; Berman AW; Choyke P; Szabo E; Rajan A; Giaccone G
    Clin Cancer Res; 2013 Mar; 19(6):1487-93. PubMed ID: 23382114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of metabolic response with
    Segreto S; Fonti R; Ottaviano M; Pellegrino S; Pace L; Damiano V; Palmieri G; Del Vecchio S
    Cancer Imaging; 2017 Mar; 17(1):10. PubMed ID: 28264726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor.
    Moon SH; Kim HS; Cho YS; Sun JM; Ahn JS; Park K; Kim BT; Ahn MJ; Lee KH
    Lung Cancer; 2016 Oct; 100():24-29. PubMed ID: 27597277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumors.
    Matsumoto I; Oda M; Takizawa M; Waseda R; Nakajima K; Kawano M; Mochizuki T; Ikeda H; Watanabe G
    Ann Thorac Surg; 2013 Jan; 95(1):305-10. PubMed ID: 23200236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours.
    Eguchi T; Yoshida K; Hamanaka K; Shiina T; Koizumi T; Kawakami S; Oguchi K; Amano J
    Eur J Cardiothorac Surg; 2012 May; 41(5):1059-62. PubMed ID: 22219437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
    Fukumoto K; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Kato K; Matsuo K; Yokoi K
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of
    Fukumoto K; Fukui T; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Sugiyama T; Kato K; Yokoi K
    World J Surg; 2017 Jul; 41(7):1828-1833. PubMed ID: 28265732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors.
    Kaira K; Sunaga N; Ishizuka T; Shimizu K; Yamamoto N
    Cancer Imaging; 2011 Nov; 11(1):195-201. PubMed ID: 22138614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.
    Endo M; Nakagawa K; Ohde Y; Okumura T; Kondo H; Igawa S; Nakamura Y; Tsuya A; Murakami H; Takahashi T; Yamamoto N; Ito I; Kameya T
    Lung Cancer; 2008 Sep; 61(3):350-5. PubMed ID: 18304691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.
    Lococo F; Cesario A; Okami J; Cardillo G; Cavuto S; Tokunaga T; Apolone G; Margaritora S; Granone P
    Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers.
    Lee G; I H; Kim SJ; Pak K; Cho JS; Jeong YJ; Lee CH; Chang S
    Clin Nucl Med; 2016 Jan; 41(1):8-14. PubMed ID: 26284773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET.
    Sasaki M; Kuwabara Y; Ichiya Y; Akashi Y; Yoshida T; Nakagawa M; Murayama S; Masuda K
    J Nucl Med; 1999 Oct; 40(10):1595-601. PubMed ID: 10520697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
    Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
    Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.